Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Gresa Arribas, Nuria ^a   Ariño, Helena ^a,b   Martínez Hernández, Eugenia ^a,b   Petit Pedrol, Mar ^a   Sabater, Lidia ^a   Saiz, Albert ^a,b   Dalmau, Josep ^a,c,d   Graus, Francesc ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ASSOCIATED PROTEIN; CELL PROTEIN; EPITOPE; GEPHYRIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE DECARBOXYLASE ANTIBODY; GLYCINE RECEPTOR; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; GLUTAMATE DECARBOXYLASE 2; ISOENZYME;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BIOASSAY; BLOOD ANALYSIS; CELL BASED ASSAY; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID EXAMINATION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVE SITE; EPILEPSY; FEMALE; HEK293 CELL LINE; HUMAN; IMMUNOBLOTTING; MALE; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; STIFF MAN SYNDROME; ANIMAL; BLOOD; CEREBROSPINAL FLUID; IMMUNOLOGY; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PRESCHOOL CHILD; PYRAMIDAL NERVE CELL; SYNAPSE; SYNDROME; YOUNG ADULT;

RATTUS; SYNAPSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CHILD, PRESCHOOL; EPITOPES; FEMALE; GABAERGIC NEURONS; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PYRAMIDAL CELLS; RATS; SYNAPSES; SYNDROME; YOUNG ADULT;

EID: 84925014241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121364     Document Type: Article

References (48)

1. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-63. doi: 10.1093/brain/awn183 PMID: 18687732
2. Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. Journal of Autoimmunity 2011;37:79-87. doi: 10.1016/j.jaut.2011.05.005 PMID: 21680149
3. Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Review of Clinical Immunology 2013;9:1043-53. doi: 10.1586/1744666X. 2013.845527 PMID: 24168411
4. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. The New England Journal of Medicine 1988;318:1012-20. PMID: 3281011
5. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to the GABA (B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology 2010;9:67-76. doi: 10.1016/S1474-4422 (09) 70324-2 PMID: 19962348
6. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Annals of Neurology 2010;67:470-8. doi: 10.1002/ana.21917 PMID: 20437582
7. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiffperson syndrome. The New England Journal of Medicine 2001;345:1870-6. PMID: 11756577
8. Ariño H, Gresa-Arribas N, Blanco Y, Martínez-Hernández E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurology 2014;71:1009-16. doi: 10.1001/jamaneurol.2014.1011 PMID: 24934144
9. Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Archives of Neurology 2004;61:902-4. PMID: 15210528
10. Manto M-U, Laute M-A, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Annals of Neurology 2007;61:544-51. PMID: 17600364
11. Hansen N, Grünewald B, Weishaupt A, Colaço MN, Toyka K V, Sommer C, et al. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Experimental Neurology 2013;239:202-9. doi: 10.1016/j.expneurol.2012.10.013 PMID: 23099416
12. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry 2004;75:1135-40. PMID: 15258215
13. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Archives of Neurology 2012;69:230-8. doi: 10.1001/archneurol.2011.991 PMID: 22332190
14. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain: A Journal of Neurology 2000;123(Pt 7):1481-94.
15. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-30. PMID: 9339684
16. Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003;60:230-4. PMID: 12552036
17. Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780-4. PMID: 11552003
18. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA (B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011;76:795-800. doi: 10.1212/WNL. 0b013e31820e7b8d PMID: 21357831
19. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurology 2013;70:44-50. doi: 10.1001/jamaneurol.2013.574 PMID: 23090334
20. Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurology 2014;13:276-86. doi: 10.1016/S1474-4422 (13) 70299-0 PMID: 24462240
21. Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128:1764-77. PMID: 15888538
22. Sabater L, Höftberger R, Boronat A, Saiz A, Dalmau J, Graus F. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PloS One 2013;8:e60438. doi: 10.1371/journal. pone.0060438 PMID: 23536908
23. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. The Journal of Neuroscience 2010;30:5866-75. doi: 10.1523/JNEUROSCI.0167-10.2010 PMID: 20427647
24. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, De Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Archives of Neurology 2001;58:225-30. PMID: 11176960
25. Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, et al. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. European Journal of Neurology 2008;15:973-80. doi: 10.1111/j.1468-1331.2008.02221.x PMID: 18637036
26. Jarius S, Stich O, Speck J, Rasiah C, Wildemann B, Meinck HM, et al. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome. Journal of Neuroimmunology 2010;229:219-24. doi: 10.1016/j.jneuroim.2010.07. 019 PMID: 20813415
27. Ishida K, Mitoma H, Wada Y, Oka T, Shibahara J, Saito Y, et al. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:190-2. PMID: 17119008
28. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006;67:1068-70. PMID: 17000981
29. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proceedings of the National Academy of Sciences of the United States of America 1993;90:2832-6. PMID: 7681990
30. Fenalti G, Hampe CS, Arafat Y, Law RHP, Banga JP, Mackay IR, et al. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 2008;57:1293-301. doi: 10.2337/db07-1461 PMID: 18184926
31. Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. The Journal of Experimental Medicine 1993;178:2097-106. PMID: 8245784
32. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. The Journal of Experimental Medicine 1994;180:595-606. PMID: 7519242
33. Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, et al. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. Journal of Immunology 2005;175:7755-62. PMID: 16301686
34. Burbelo PD, Groot S, Dalakas MC, Iadarola MJ. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochemical and Biophysical Research Communications 2008;366:1-7. PMID: 18047830
35. Manto MU, Hampe CS, Rogemond V, Honnorat J. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia. Orphanet Journal of Rare Diseases 2011;6:3. doi: 10.1186/1750-1172-6-3 PMID: 21294897
36. Tyagarajan SK, Fritschy J-M. Gephyrin: a master regulator of neuronal function? Nature Reviews Neuroscience 2014;15:141-56. doi: 10.1038/nrn3670 PMID: 24552784
37. Butler MH, Hayashi A, Ohkoshi N, Villmann C, Becker CM, Feng G, et al. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 2000;26:307-12. PMID: 10839351
38. Chen Z-W, Olsen RW. GABAA receptor associated proteins: a key factor regulating GABAA receptor function. Journal of Neurochemistry 2007;100:279-94. PMID: 17083446
39. Raju R, Rakocevic G, Chen Z, Hoehn G, Semino-Mora C, Shi W, et al. Autoimmunity to GABAA-receptorassociated protein in stiff-person syndrome. Brain 2006;129:3270-6. PMID: 16984900
40. Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Annals of the New York Academy of Sciences 2014 [Epub ahead of print].
41. Chang T, Alexopoulos H, McMenamin M, Carvajal-González A, Alexander SK, Deacon R, et al. Neuronal Surface and Glutamic Acid Decarboxylase Autoantibodies in Nonparaneoplastic Stiff Person Syndrome. JAMA Neurology 2013;70:1140-9. PMID: 23877118
42. Alexopoulos H, Akrivou S, Dalakas MC. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology 2013;81:1962-4. doi: 10.1212/01.wnl.0000436617.40779.65 PMID: 24174585
43. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Annals of Neurology 1998;44:194-201. PMID: 9708541
44. Hampe CS, Petrosini L, De Bartolo P, Caporali P, Cutuli D, Laricchiuta D, et al. Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats. Orphanet Journal of Rare Diseases 2013;8:82. doi: 10.1186/1750-1172-8-82 PMID: 23738610
45. Han G, Li Y, Wang J, Wang R, Chen G, Song L, et al. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD (500-585). Journal of Immunology 2005;174:4516-24. PMID: 15814672
46. Chang T, Alexopoulos H, Pettingill P, McMenamin M, Deacon R, Erdelyi F, et al. Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss. PloS One 2013;8:e72921. doi: 10.1371/journal.pone.0072921 PMID: 24058450
47. Vega-Flores G, Rubio SE, Jurado-Parras MT, Gómez-Climent MÁ, Hampe CS, Manto M, et al. The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning. Cerebral Cortex 2014;24:2093-107. doi: 10.1093/cercor/bht060 PMID: 23479403
48. Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, et al. Human Nmethyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 2015;138:94-109. doi: 10.1093/brain/awu310 PMID: 25392198